Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.36 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 7/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.33 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14798240 | 0.92 | BCL2L1 (0.35) | BCL2L1BAK1ALDH1A1SMN1; SMN2CA2 | |
| SCHEMBL14798246 | 0.82 | CA2 (0.34) | BCL2L1BAK1ALDH1A1SMN1; SMN2CA2 | |
| SCHEMBL10598490 | 0.80 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2CA2CA9CA1 | |
| SCHEMBL14798582 | 0.80 | TSHR (0.39) | BCL2L1BAK1ALDH1A1SMN1; SMN2CA2 | |
| SCHEMBL17076870 | 0.79 | CA2 (0.36) | BCL2L1BAK1SMN1; SMN2CA2CA9 | |
| SCHEMBL31594518 | 0.79 | CA2 (0.53) | BCL2L1BAK1ALDH1A1SMN1; SMN2CA2 | |
| SCHEMBL11122852 | 0.77 | BCL2L1 (0.31) | BCL2L1BAK1MMP2MMP9MMP8 | |
| SCHEMBL332136 | 0.77 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2CA2CA9CA1 | |
| SCHEMBL6014622 | 0.77 | CA2 (0.45) | BCL2L1BAK1SMN1; SMN2CA2CA9 | |
| SCHEMBL14798581 | 0.77 | CA2 (0.38) | BCL2L1BAK1SMN1; SMN2CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059403-A | Epoxy resin composition, preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2025-05-30 | — | — | CN | claimed |
| US-11656224-B2 | Multivalent glycan microarray platform | Z BIOTECH LLC (US) | 2023-05-23 | — | — | US | claimed |
| US-20220145111-A1 | INKJET OVERCOAT COMPOSITION | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2022-05-12 | — | — | US | claimed |
| US-20220099666-A1 | MULTIVALENT GLYCAN MICROARRAY PLATFORM | Z BIOTECH, LLC (US) | 2022-03-31 | — | — | US | claimed |
| US-11231415-B2 | Multivalent glycan microarray platform | Z BIOTECH LLC (US) | 2022-01-25 | — | — | US | claimed |
| WO-2021112816-A1 | INKJET OVERCOAT COMPOSITION | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-06-10 | — | — | WO | claimed |
| US-20190128881-A1 | Multivalent Glycan Microarray Platform | Z BIOTECH, LLC (US) | 2019-05-02 | — | — | US | claimed |
| EP-1218422-A1 | AZIDOSILANE-MODIFIED, MOISTURE-CURABLE POLYOLEFIN POLYMERS, PROCESS FOR MAKING, AND ARTICLES OBTAINED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 2002-07-03 | — | — | EP | claimed |
| WO-2001010914-A1 | AZIDOSILANE-MODIFIED, MOISTURE-CURABLE POLYOLEFIN POLYMERS, PROCESS FOR MAKING, AND ARTICLES OBTAINED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 2001-02-15 | — | — | WO | claimed |
| CN-120059403-A | Epoxy resin composition, preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2025-05-30 | — | — | CN | disclosed |
| US-20250075101-A1 | SURFACE TREATMENT | Interphase Materials, Inc (US) | 2025-03-06 | — | — | US | disclosed |
| CN-119463589-A | Ultralow-thermal-conductivity self-rebound heat-insulation protective coating and protective coating | 江苏苏博特新材料股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12146071-B2 | Surface treatment | INTERPHASE MATERIALS INC. (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240326090-A1 | METHODS AND SYSTEMS FOR SUBSTRATE FUNCTIONALIZATION | ULTIMA GENOMICS, INC. | 2024-10-03 | — | — | US | disclosed |
| US-20150273061-A1 | DEGRADABLE SILICA NANOSHELLS FOR ULTRASONIC IMAGING/THERAPY | UNIV CALIFORNIA (US) | 2015-10-01 | — | — | US | disclosed |
| US-20130131779-A1 | SILANE BONDED MEDICAL DEVICES AND METHOD OF MAKING SAME | COOK MEDICAL TECHNOLOGIES LLC (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2594296-A2 | Silane bonded medical devices and method of making same | Cook Medical Technologies LLC (US) | 2013-05-22 | — | — | EP | disclosed |
| EP-1218422-A1 | AZIDOSILANE-MODIFIED, MOISTURE-CURABLE POLYOLEFIN POLYMERS, PROCESS FOR MAKING, AND ARTICLES OBTAINED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 2002-07-03 | — | — | EP | disclosed |
| US-6331597-B1 | Azidosilane-modified, moisture-curable polyolefin polymers, process for making, and articles obtained therefrom | THE DOW CHEMICAL COMPANY | 2001-12-18 | — | — | US | disclosed |
| WO-2001010914-A1 | AZIDOSILANE-MODIFIED, MOISTURE-CURABLE POLYOLEFIN POLYMERS, PROCESS FOR MAKING, AND ARTICLES OBTAINED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 2001-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150273061-A1 | DEGRADABLE SILICA NANOSHELLS FOR ULTRASONIC IMAGING/THERAPY | SON, MMP1, FAU | BCL2L1 204/4885BAK1 755/4885ALDH1A1 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.